The influence of genetic variants of sorafenib on clinical outcomes and toxic effects in patients with advanced renal cell carcinoma.
Qin C, Cao Q, Li P, Wang S, Wang J, Wang M, Chu H, Zhou L, Li X, Ye D, Zhang H, Huang Y, Dong B, Sun X, Zou Q, Cai H, Sun L, Zhu J, Liu F, Ji J, Cui L, Wang X, Zhou H, Zhao H, Wu B, Chen J, Jiang M, Zhang Z, Shao P, Ju X, Yin C.
Qin C, et al. Among authors: cai h.
Sci Rep. 2016 Feb 2;6:20089. doi: 10.1038/srep20089.
Sci Rep. 2016.
PMID: 26830973
Free PMC article.
Clinical Trial.